Goldman Sachs Starts Sagimet Biosciences Inc (SGMT) at Buy, 'Targeting a precision medicine approach for NASH'
Tweet Send to a Friend
(Updated - August 8, 2023 5:24 AM EDT)
Goldman Sachs analyst Andrea Tan initiates coverage on Sagimet Biosciences Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Andrea Tan initiates coverage on Sagimet Biosciences Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
